
PMC:7346000 / 21172-21354
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T54 | 143-148 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T23 | 143-148 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
588 | 22-24 | Chemical | denotes | GM | MESH:C012990 |
589 | 149-151 | Chemical | denotes | GM | MESH:C012990 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T169 | 15-16 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T170 | 25-33 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test was |
T171 | 61-62 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T172 | 94-95 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T173 | 164-165 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T123 | 22-24 | Chemical | denotes | GM | http://purl.obolibrary.org/obo/CHEBI_74120 |
T124 | 149-151 | Chemical | denotes | GM | http://purl.obolibrary.org/obo/CHEBI_74120 |
LitCovid-PD-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
---|---|---|---|---|---|
T8 | 22-24 | GlycoEpitope | denotes | GM | http://www.glycoepitope.jp/epitopes/EP0510 |
T9 | 149-151 | GlycoEpitope | denotes | GM | http://www.glycoepitope.jp/epitopes/EP0510 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T111 | 0-182 | Sentence | denotes | In those where a BALF GM test was performed, 14/23 (61%) had a titer ≥1.5 ODI and 16/23 (70%) a titer ≥0.5 ODI, while 6/28 (21%) of those with serum GM results had a titer > 0.5 ODI. |